iCAD

iCAD, a global medical technology leader providing innovative enhanced cancer detection and therapy solutions for more than 6,000 facilities worldwide, offers a wide range of powerful tools for clinicians to support cancer detection, while enhancing workflow efficiency. iCAD’s Breast Health Solutions include the ProFound AI platform, a high-performing, concurrent-read workflow solution built on the latest deep-learning artificial intelligence that rapidly analyzes each tomosynthesis image to detect malignant soft tissue densities and calcifications with unrivaled accuracy, and PowerLook Density Assessment, which assists radiologists in determining the patient’s appropriate breast density category. This powerful platform is scalable for new applications, including ProFound AI Risk, the first and only clinical decision support tool that provides an accurate two-year, breast cancer risk estimation that is truly personalized for each woman, based only on a screening mammogram.

Applications by this vendor

PowerLook® Density Assessment

FDA, CE & Health Canada | DBT & FFDM

PowerLook Density Assessment is a software application intended for use with 2D FFDM and 2D Synthetic mammography images. PowerLook Density Assessment provides a BI-RADS 5th Edition breast density category to aid health care professionals in the assessment of breast tissue composition. PowerLook Density Assessment produces adjunctive information. It is not a diagnostic aid.

ProFound AI® for 2D Mammography

CE & Health Canada | FFDM

ProFound AI® 2D is a computer-assisted detection and diagnosis Artificial Intelligence (AI) software device intended to be used by interpreting physicians while reading 2D mammography exams from compatible 2D mammography systems. The system detects soft tissue densities (masses, architectural distortions and asymmetries) and calcifications in mammography images. The detections and certainty of finding, and case scores assist interpreting physicians in identifying soft tissue densities and calcifications that may be confirmed or dismissed.

ProFound AI® for DBT

FDA, CE & Health Canada | DBT

ProFound AI® for DBT software is a computer-assisted detection and diagnosis (CAD) software device intended to be used concurrently by physicians while reading digital breast tomosynthesis (DBT) exams from compatible DBT systems. The system detects soft tissue densities (masses, architectural distortions and asymmetries) and calcifications in the 3D DBT slices. The detections and Certainty of Finding and Case Scores assist interpreting physicians in identifying soft tissue densities and calcifications that may be confirmed or dismissed by the interpreting physician.